Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer's Patient Review Abstract Alzheimer's disease is often marked by progressive episodic memory loss, but not all patients start with an amnestic syndrome. Some patients may initially present with issues in visual-spatial skills, language, executive function,

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early

Plasma Biomarkers for Neurodegenerative Disease: What Clinicians Need to Know in 2026

Plasma Biomarkers for Neurodegenerative Disease What Clinicians Need to Know in 2026 Review Key Takeaways Plasma biomarkers are rapidly transforming the diagnosis and management of Alzheimer’s disease and related dementias, representing one of the most notable advances in neurodegenerative medicine in recent decades. Historically, the definitive assessment of Alzheimer’s pathology has

Hearing Loss And Functional Decline

Hearing Loss And Functional Decline Overview Hearing loss has been recognized as one of the major modifiable risk factors for cognitive decline and dementia. However, studies exploring this connection have yielded mixed results. This study aimed to assess the long-term relationship between self-reported hearing loss and cognitive/functional abilities in 695 cognitively

Cataract Surgery Impact On Cognitive Test Scores

Cataract Surgery Impact On Cognitive Test Scores Overview This prospective observational study aimed to assess the impact of cataract surgery on mild cognitive impairment (MCI) and dementia in individuals aged 75 years and older. Conducted between 2019 and 2021, the study involved 88 eligible patients who underwent cataract surgery. Cognitive function was

Alzheimer’s Patients and Low Tau Burden Outcomes

Alzheimer's Patients and Low Tau Burden Outcomes Overview The study focuses on individuals within the Alzheimer's Disease (AD) pathway exhibiting abnormal amyloid-beta (Aβ) and tau deposition. Specifically, it investigates a subgroup characterized by low tau levels (A+T−) and compares them to their counterparts with higher tau levels (A+T+).   The research involves 397 individuals

Posterior Cortical Atrophy, Primary Progressive Aphasia, and the Non-Amnestic Alzheimer’s Patient